PA
GWPH

Perceptive Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Perceptive Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-36,763
Closed -$3.73M – 164
2017
Q3 		$3.73M Buy
+36,763
New +$3.94M 0.14% 78
2016
Q2 		– Sell
-13,109
Closed -$946K – 215
2016
Q1 		$946K Buy
+13,109
New +$719K 0.08% 103

Other funds holding GWPH

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Perceptive Advisors's GWPH Position: Q4 2017 in Review

Perceptive Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2017, closing a stake of 36,763 shares — an estimated $3.73M sold.

Perceptive Advisors first reported a position in GWPH in Q1 2016 and held it in 2 quarters. The position peaked at $3.73M in Q3 2017. 204 funds tracked by Wall St. Rank hold GWPH as of Q4 2017.

  • Perceptive Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2017 after selling out during the quarter.
  • Perceptive Advisors sold 36,763 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2017, an estimated $3.73M.
  • Perceptive Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2016 and held it in 2 quarters.
  • Perceptive Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.73M in Q3 2017.
  • 204 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2017.

Based on Perceptive Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.